Last updated 26 days ago

A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)

80 patients around the world
Available in Spain, Brazil, United States
Takeda
1Research sites
80Patients around the world
This study is for people with
Cytomegalovirus
Requirements for the patient
To 17 Years
All Gender
Medical requirements
Sites
Hospital de Clínicas de Porto Alegre
Recruiting
Santa Cecília, Porto Alegre - RS, 90450-190, Brazil
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy